Ujin Pharma Ltd filed DRHP with SEBI on Jun 22, 2026, for its proposed Initial Public Offering (IPO).
According to the DRHP, the public issue comprises a fresh issue of up to 1.19 crore equity shares and an Offer for Sale (OFS) of up to 0.73 crore shares by existing shareholders.
SMC Capitals Ltd. is the Book Running Lead Manager for the IPO and Kfin Technologies Ltd. is the Registrar.
About the Company
Incorporated in May 2024, Ujin Pharma Limited is a chemical distribution and supply company engaged in the trading and distribution of solvents, specialty chemicals, acids, monomers, pharmaceutical raw materials, and nutraceuticals. The company serves a diverse customer base across pharmaceuticals, agrochemicals, specialty chemicals, petrochemicals, automotive, paints & coatings, printing inks, packaging, and industrial sectors.IPO Category wise Issue Reservation
According to the draft red herring prospectus, Not more than 50% of the Net Offer is reserved for Qualified Institutional Bidders (QIBs), Not less than 15% of the Net Offer for Non-Institutional Investors (NIIs) and Not less than 35% of the Net Offer for Retail Individual Investors (RIIs).
Ujin Pharma IPO Fund Utilization
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Investment in Altra Agro-Chem Private Limited, Associate Company, by way of subscription to equity shares for making it Subsidiary | 61.72 |
| 2 | Investment in Altra Pharma-Chem Private Limited, Associate Company, by way of subscription to equity shares for making it Subsidiary | 21.64 |
| 3 | Repayment or pre-payment, in in part or full of certain borrowings availed by the Company from financial institutions | 25.00 |
| 4 | General Corporate Purposes | |
| Total | 108.37 |
Financial Performance Highlights:
Ujin Pharma Ltd.’s total income grew by 9%, reached ₹1,636.06 crore in Mar 31, 2025, compared to ₹1,497.33 crore in Mar 31, 2024.
For the same period, profit after tax declined 10% to ₹14.29 crore, compared to ₹16.01 crore.
For the latest period ended on Dec 31, 2025, its total income stood at ₹1,523.11 crore and PAT stood at ₹25.47 crore.
